InsiderTrades

Form 4 for MRNA Moderna

Accepted 2025-02-28 00:00:00 ET · period of report 2025-02-27 · accession 0001127602-25-007265 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-02-28 2025-02-27 MRNA Klinger Shannon Thyme CLO M - OptEx — +5,747 24.9K +30% —
DM 2025-02-28 2025-02-27 MRNA Klinger Shannon Thyme CLO F - Tax $33.58 -2,779 24.7K -10% -$93.3K
DM 2025-02-28 2025-02-27 MRNA Klinger Shannon Thyme CLO M - OptEx $0.00 -5,747 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-27 M A 2,653 — 26,018 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Common Common Stock 2025-02-27 F D 1,496 $33.58 23,365 D — —
3 Common Common Stock 2025-02-27 M A 3,094 — 24,861 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) Includes 342 shares acquired under the Moderna, Inc. 2018 Employee Stock Purchase Plan on December 13, 2024.
4 Common Common Stock 2025-02-27 F D 1,283 $33.58 24,735 D — —
5 Derivative Restricted Stock Units 2025-02-27 M D 3,094 $0.00 9,283 D — · — to — 3,094 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
6 Derivative Restricted Stock Units 2025-02-27 M D 2,653 $0.00 0 D — · — to — 2,653 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on May 27, 2024 with the remainder vesting in three (3) equal quarterly installments thereafter.